Cargando…
The pharmacological role of histone demethylase JMJD3 inhibitor GSK-J4 on glioma cells
Glioma is regarded as the most prevalent malignant carcinoma of the central nervous system, and lack of effective treatment. Thus, the development of new therapeutic strategies targeting glioma is of significant clinical importance. In the present study, histone H3K27 demethylase jumonji domain-cont...
Autores principales: | Sui, Aixia, Xu, Yongbing, Li, Yitong, Hu, Qilu, Wang, Zeyang, Zhang, Hongtao, Yang, Junjie, Guo, Xiaoqiang, Zhao, Wenqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5620280/ https://www.ncbi.nlm.nih.gov/pubmed/28978140 http://dx.doi.org/10.18632/oncotarget.19793 |
Ejemplares similares
-
The JMJD3 histone demethylase inhibitor GSK-J1 ameliorates lipopolysaccharide-induced inflammation in a mastitis model
por: Wang, Jing-Jing, et al.
Publicado: (2022) -
Therapeutic potential of GSK-J4, a histone demethylase KDM6B/JMJD3 inhibitor, for acute myeloid leukemia
por: Li, Yunan, et al.
Publicado: (2018) -
Histone demethylase JMJD3 is required for osteoblast differentiation in mice
por: Zhang, Feng, et al.
Publicado: (2015) -
Histone demethylase JMJD2C: epigenetic regulators in tumors
por: Zhang, Chengcheng, et al.
Publicado: (2017) -
The Roles of Histone Demethylase Jmjd3 in Osteoblast Differentiation and Apoptosis
por: Yang, Di, et al.
Publicado: (2017)